Becton, Dickinson and Company (BDX)
| Market Cap | 71.08B |
| Revenue (ttm) | 20.03B |
| Net Income (ttm) | 1.83B |
| Shares Out | 285.06M |
| EPS (ttm) | 6.35 |
| PE Ratio | 39.27 |
| Forward PE | 18.80 |
| Dividend | $3.44 (1.38%) |
| Ex-Dividend Date | Jun 8, 2022 |
| Volume | 1,116,114 |
| Open | 244.58 |
| Previous Close | 244.53 |
| Day's Range | 243.62 - 251.17 |
| 52-Week Range | 229.40 - 277.29 |
| Beta | 0.66 |
| Analysts | Buy |
| Price Target | 289.31 (+16.0%) |
| Earnings Date | Aug 4, 2022 |
About BDX
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devic... [Read more...]
Financial Performance
In 2021, BDX's revenue was $20.25 billion, an increase of 18.29% compared to the previous year's $17.12 billion. Earnings were $2.09 billion, an increase of 139.36%.
Financial StatementsAnalyst Forecast
According to 22 analysts, the average rating for BDX stock is "Buy." The 12-month stock price forecast is 289.31, which is an increase of 16.03% from the latest price.
News
BD (BDX) Integrates Innovative Solution to Boost Patient Care
BD's (BDX) announcement of the implementation of BD HealthSight brings together timely monitoring to support the early detection of emerging healthcare infections, thereby improving patient care.
BD's (BDX) Latest Collaboration to Enhance Patient Care
BD's (BDX) new partnership is expected to increase efficiency for new clinical trials, generate evidence, support new claims for its products and streamline medical device regulatory submissions.
BD Collaborates with Mayo Clinic Platform, Leveraging Real-World Clinical Data to Improve Post-Market Device Surveill...
BD is among the first companies to enter innovative partnership with Mayo Clinic Platform for access to world's largest collection of clinical data FRANKLIN LAKES, N.J. , June 13, 2022 /PRNewswire/ -- ...
BD's (BDX) New Tie-Up to Develop Detection Kit for Monkeypox
BD's (BDX) partnership with CerTest is expected to aid in advancing the understanding of the monkeypox virus' global spread.
BD entering the new pharmacy automation solutions space via the Parata Systems acquisition
Becton, Dickson and Company (NYSE: BDX), a top medical tech corporation also known as BD, and leading private equity company, Frazier Healthcare Partners, announced they had entered into a definitive me...
BD (BDX) to Expand Base in Pharmacy Automation With New Buyout
BD's (BDX) buyout of Parata Systems is expected to advance its 2025 strategy to accelerate innovation in smart, connected care and enabling new care settings.
CerTest Biotec and BD Announce Collaboration on Molecular Diagnostic Test for Monkeypox
CerTest Biotec Uses the BD MAX™ Molecular Diagnostic System Open System Reagent Suite to Develop RT-PCR Detection Kit ZARAGOZA, Spain and FRANKLIN LAKES, N.J., June 8, 2022 /PRNewswire/ -- CerTest Biote...
BD Names Simon Campion as Medical Segment President
FRANKLIN LAKES, N.J. , June 7, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has appointed Simon Campion as executi...
BD's (BDX) Latest Product to Transform Research Outcome
BD's (BDX) latest cell sorting technology is expected to speed up the process of cell sorting as well as provide answers to previously unthinkable questions.
BD TO ACQUIRE PARATA SYSTEMS TO ENTER NEW PHARMACY AUTOMATION SOLUTIONS MARKET
Expands BD Transformative Solutions to Provide New Pharmacy Automation Technologies for Hospitals, Retail Pharmacy, Long-Term Care and Home Settings Advances BD 2025 Strategy to Accelerate Innovation in...
BD Unveils World's First Spectral Cell Sorter with High-Speed Imaging Technology that Sorts Cells Based on Visual Cha...
BD FACSDiscover™ S8 Cell Sorter with BD CellView™ Image Technology First to Combine Spectral Flow Cytometry with Sort-Capable Imaging FRANKLIN LAKES, N.J. , June 3, 2022 /PRNewswire/ -- BD (Becton, Dick...
BD to Present at Goldman Sachs 43rd Annual Global Healthcare Conference
FRANKLIN LAKES, N.J. , June 2, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Goldman Sachs...
3 Top Dividend Kings to Buy for the Long Haul
A bear market can test investors' patience, but these companies can help you survive.
New Strong Sell Stocks for May 27th
ACER, BBWI, and BDX have been added to the Zacks Rank #5 (Strong Sell) List on May 27, 2022.
New Strong Sell Stocks for May 25th
ALGN, AUD, and BDX have been added to the Zacks Rank #5 (Strong Sell) List on May 25, 2022.
3 Dividend Kings Trading for Bargain Prices
This suggests that ABM Industries, Becton, Dickinson & Company, and Dover could be good options for investors looking for high levels of total returns and secure income. The post 3 Dividend Kings Tradin...
Buy These 2 Rock-Solid Stocks Instead of Exiting the Market
You'll sleep better at night, and you'll also probably get richer than if you were holding cash.
BD (BDX) Introduces New Molecular Diagnostic Platform in US
BD's (BDX) new fully-automated, high-throughput infectious disease molecular diagnostics platform in the United States to aid lab technicians in prioritizing higher value work.
BD (BDX) Extends Partnership to Boost Diagnostic Blood Collection
BD (BDX) expands strategic partnership with Babson Diagnostics that will enable less invasive blood sample collection easier and patient-centric.
New Strong Sell Stocks for May 13th
DDD, AMRN, and BDX have been added to the Zacks Rank #5 (Strong Sell) List on May 13, 2022.
BD Launches Fully Automated, High-Throughput Infectious Disease Molecular Diagnostic Platform in the U.S.
510(k) Clearance of BD COR™ MX Instrument Elevates Standard of Care for Sexually Transmitted Infections FRANKLIN LAKES, N.J. , May 12, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX)...
Babson, BD Expand Strategic Partnership to Advance Diagnostic Blood Collection in New Care Settings
Expanded Collaboration Agreement to Make Less Invasive Blood Sample Collection More Convenient and Patient Centered AUSTIN, Texas and FRANKLIN LAKES, N.J. , May 11, 2022 /PRNewswire/ -- Babson Diagnosti...
7 Stock Picks to Play the Post-Pandemic Return of Dental Visits
Although Covid-19 allowed people the excuse to not see their dentist, the necessary return could benefit these dental stocks to buy. The post 7 Stock Picks to Play the Post-Pandemic Return of Dental Vis...
BD (BDX) Beats on Q2 Earnings and Revenues, Revises FY22 View
The majority of BD's (BDX) core units witness strong revenue growth in the fiscal second quarter.
Becton Dickinson (BDX) Q2 Earnings and Revenues Surpass Estimates
Becton Dickinson (BDX) delivered earnings and revenue surprises of 6.71% and 3.12%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?